Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-12

Clinical Trial Update: Safety and Efficacy of a New Formulation of Bimatoprost/Timolol Ophthalmic Solution Compared With Bimatoprost/Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing a new formulation of bimatoprost/timolol ophthalmic solution with the standard formulation in patients with glaucoma or ocular hyperte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ganfort (bimatoprost; timolol)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2013-03-12